| Line Item | 2026-03-28 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $281.5M | -48.4% | +8.4% |
| Cost of Revenue | $156.9M | -46.3% | +7.3% |
| Gross Profit | $124.6M | -50.8% | +9.7% |
| R&D Expense | $64.1M | +7.3% | -17.2% |
| SG&A Expense | $29.7M | +6.1% | -10.5% |
| Operating Income | -$31.6M | -131.4% | +48.4% |
| Pre-tax Income | -$31.1M | -130.5% | +47.4% |
| Income Tax | -$2.2M | -127.1% | -120.4% |
| Net Income | -$28.9M | -130.8% | +58.8% |
| EPS (Basic) | -$0.24 | -130.8% | +58.6% |
| EPS (Diluted) | -$0.24 | -132.0% | +58.6% |
| Line Item | 2026-03-28 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $200.2M | -36.0% | +15.6% |
| Accounts Receivable | $95.5M | -17.9% | +136.2% |
| Inventory | $160.8M | +28.3% | +16.2% |
| Current Assets | $540.1M | -15.6% | +19.2% |
| Total Assets | $839.5M | -11.4% | +6.0% |
| Current Liabilities | $341.1M |
| Line Item | 2026-03-28 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $97.9M | -40.0% | — |
| Capital Expenditures | $10.7M | +80.2% | — |
| Investing Cash Flow | -$6.8M | -67.6% | — |
| Financing Cash Flow | -$66.7M | -184.8% | — |
| Free Cash Flow | $87.2M | -44.6% | — |
| +17.8% |
| Total Liabilities | $455.1M | -9.8% | +11.2% |
| Stockholders' Equity | $384.4M | -13.3% | +0.4% |